PayPay Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.3K Hold
33
0.2% 86
2026
Q1
$6.9K Sell
33
-9
-21% -$2K 0.24% 96
2025
Q4
$9.6K Buy
42
+9
+27% +$2.05K 0.28% 76
2025
Q3
$7.64K Hold
33
0.27% 66
2025
Q2
$6.13K Buy
33
+3
+10% +$558 0.3% 54
2025
Q1
$6.41K Sell
30
-13
-30% -$2.53K 0.37% 61
2024
Q4
$7.64K Buy
43
+8
+23% +$1.47K 0.33% 53
2024
Q3
$6.91K Buy
35
+2
+6% +$373 0.62% 30
2024
Q2
$5.66K Sell
33
-4
-11% -$663 0.47% 52
2024
Q1
$6.74K Sell
37
-8
-18% -$1.38K 0.34% 47
2023
Q4
$7.13K Sell
45
-21
-32% -$3.06K 0.35% 50
2023
Q3
$588 Buy
66
+28
+74% +$4.11K 0.03% 183
2023
Q2
$5.12K Sell
38
-9
-19% -$1.32K 0.31% 46
2023
Q1
$7.49K Sell
47
-28
-37% -$4.28K 0.5% 32
2022
Q4
$12.1K Buy
+75
New +$11.5K 0.81% 25

Other funds holding ABBV

PayPay Securities's ABBV Position: Q2 2026 in Review

PayPay Securities held its AbbVie (ABBV) position steady in Q2 2026 at 33 shares worth $8.3K. The position accounts for 0.2% of the portfolio, ranked #86.

PayPay Securities first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $12.1K in Q4 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • PayPay Securities held 33 shares of AbbVie worth $8.3K as of Q2 2026.
  • PayPay Securities left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.2% of PayPay Securities's portfolio in Q2 2026, its #86 holding.
  • PayPay Securities first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's AbbVie position peaked at $12.1K in Q4 2022.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.